article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy 

Bill of Health

The selections feature topics ranging from an analysis of government and industry investments for recently approved drugs, to a discussion of court decisions on mifepristone, and an examination of the added therapeutic benefit associated with the top-selling brand-name drugs in Medicare. JAMA Health Forum. 2023 Apr 7;4(4):e230511.

article thumbnail

Healthcare Industry Warned About Risk Posed by APT41 Threat Group

HIPAA Journal

APT41 – also known as Double Dragon, Barium, Winnti, Wicked Panda, Wicked Spider, TG-2633, Bronze Atlas, Red Kelpie – conducted targeted campaigns on the healthcare sector in 2014, 2015, 2016, 2018, 2019, and 2020. The post Healthcare Industry Warned About Risk Posed by APT41 Threat Group appeared first on HIPAA Journal.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – May

SQA

It is not intended to provide information on the terms and procedures directly associated with regulatory requirements governing cell-based products. 88, Microbial Data Deviation Investigations in the Pharmaceutical Industry, January 2022. 536/2014 on Clinical Trials, which will replace EU Annex 13.

article thumbnail

SQA Regulatory Surveillance Summary 5 | Monthly Update 2021

SQA

ISO 18082:2014, Anesthetic and respiratory equipment – Dimensions of non-interchangeable screw-threaded (NIST) low pressure connectors for medical gases. This technical report focuses on the challenges facing the pharmaceutical industry that use complex packaging systems for sterile drugs and biologics (e.g.,

FDA 83
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

International Pharmaceutical Excipients Council (IPEC) Updated: IPEC Glossary of Terms and Acronyms, 14 December 2023 The IPEC Federation announces the availability of the revised and updated IPEC General Glossary of Terms and Acronyms for Pharmaceutical Excipients (version 2, 2021).

FDA 52